Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAVATAN vs New Travoprost Formulation in Glaucoma and Ocular Hypertension
NCT01452009Phase 3Withdrawn
- Sponsor
- Alcon Inc.
- Start
- Nov 2011
- Primary completion
- Dec 2011
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 3 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Planned start Nov 2011; status: withdrawn.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01452009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452009.